APC anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_APC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
  • GK1.5_APC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) APC (filled histogram) or rat IgG2b, κ APC isotype control (open histogram).
See APC spectral data
Cat # Size Price Quantity Avail. Save
100411 25 µg 28€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100412 100 µg 96€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, and immunoprecipitation1,2. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
Product Citations
  1. Ando T, et al. 2017. Inflammation. 10.1007/s10753-017-0613-6. PubMed
  2. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  3. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  4. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  5. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  6. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  7. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  8. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  9. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  10. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  11. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  12. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  13. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  14. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  15. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  16. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  17. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  18. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  19. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  20. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  21. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  22. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  23. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  24. Chisolm DA et al. 2019. Immunity. 51(1):155-168 . PubMed
  25. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  26. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  27. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  28. Ren G et al. 2017. Molecular cell. 67(6):1049-1058 . PubMed
  29. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  30. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  31. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  32. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  33. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  34. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  35. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  36. Zou D, et al. 2020. EBioMedicine. 52:102652. PubMed
  37. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  38. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  39. Pein M, et al. 2020. Nat Commun. 11:1494. PubMed
  40. Bosnjak B, et al. 2019. Front Immunol. 10:840. PubMed
  41. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  42. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  43. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  44. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  45. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  46. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  47. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  48. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  49. Zhu P, et al. 2012. J Cereb Blood Flow Metab. 0.482638889. PubMed
  50. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  51. Yu X, et al. 2013. Cancer Res. 73:2093. PubMed
  52. Lo W, et al. 2014. Elife. 14:1457. PubMed
  53. Inoue M, et al. 2014. Proc Natl Acad Sci U S A. 111:5295. PubMed
  54. Schadler K, et al. 2014. Cancer Res. 74:2171. PubMed
  55. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  56. Wu C, et al. 2014. J Mol Cell Cardiol. 76:33. PubMed
  57. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  58. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  59. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  60. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  61. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  62. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  63. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  64. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  65. Canto F, et al. 2016. Sci Rep. 6:28573. PubMed
  66. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  67. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  68. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  69. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  70. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  71. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  72. Nakajima-Adachi H, et al. 2017. PLoS One. 12(2):e0172795. PubMed
  73. Li J, et al. 2020. Elife. 9:00. PubMed
  74. Yang J, et al. 2020. Nature. 586:572. PubMed
  75. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  76. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  77. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  78. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  79. Luo Z, et al. 2020. J Virol. 94:00:00. PubMed
  80. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  81. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  82. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  83. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
RRID
AB_312696 (BioLegend Cat. No. 100411)
AB_312697 (BioLegend Cat. No. 100412)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account